Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
6
×
life sciences
national blog main
new york blog main
6
×
startups
6
×
biotech
boston blog main
boston top stories
national top stories
new york top stories
san francisco blog main
san diego blog main
san francisco top stories
fda
san diego top stories
vc
wisconsin blog main
wisconsin top stories
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cell therapy
crispr
detroit blog main
detroit top stories
digital health
eli lilly
fulcrum therapeutics
gene therapy
generic drugs
indiana blog main
indiana top stories
investing
ipo
medical devices
migraine
national
novartis
What
new
6
×
startup
bio
biotech
called
drugs
medicines
roundup
venture
absorb
address
aiming
aims
ambys
approach
approval
bails
based
big
bigger
biogen’s
biopharmaceutical
body
brain
brand
bridgebio
builds
capital
car
cerevasc
companies
control
convo
deadly
deal
deals
debuted
debuts
develop
developing
Language
unset
Current search:
new
×
startups
×
deals
×
" new york blog main "
×
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?